Trial intelligence / Profile preview

Mirtazapine and Driving Safety in MDD

NCT00385437Phase 2Completed

Sponsor
University Health Network
Start
Apr 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of mirtazapine in major depressive disorder (MDD), sponsored by University Health Network. Started Apr 2003; status: completed.

02

Drugs

mirtazapine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00385437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00385437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call